Reason for request
Inclusion for an extension of indication
Clinical Benefit
| Substantial |
The actual benefit of VOTRIENT is substantial in th is indication. |
Clinical Added Value
| minor |
VOTRIENT has a minor IAB (level IV) in terms of efficacy compared with the current treatment strategy. |
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
qMRwHvshJMzM97um
